Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide's effectiveness depends on finding your optimal dose—a process called titration that typically spans 16 to 20 weeks. Most patients begin at 0.25 mg weekly and gradually increase, with clinical trials showing sustained weight loss of 15% to 22% at therapeutic doses. Knowing when and how to adjust your treatment helps you achieve results without unnecessary plateaus or side effects.

Understanding Semaglutide Titration: The Gradual Approach

Semaglutide titration follows a step-by-step protocol designed to minimize side effects while your body adapts. Starting at the lowest dose (0.25 mg) allows your digestive system to acclimate to how the medication works. Each week, your dose increases by 0.25 mg until you reach the target maintenance dose, typically 1.0 to 2.4 mg weekly depending on your clinical needs and response.

The gradual increase matters because semaglutide's mechanism—slowing stomach emptying and reducing appetite signals in your brain—can cause nausea or fatigue if introduced too quickly. By spacing increases one week apart, most patients experience fewer gastrointestinal side effects and better medication tolerance. Your PlexusDx provider monitors your progress at each step to ensure the pace works for your individual health profile.

Signs You're Ready for a Dose Increase

After one week at your current dose, you're typically ready to move to the next tier if side effects are minimal and manageable. Watch for hunger returning to baseline levels, weight loss slowing despite adherence, or your appetite control weakening—these suggest your body has adapted and may benefit from a higher dose. Some patients also notice improved energy or fewer nausea symptoms after a few days at a stable dose, signaling readiness for the next step.

PlexusDx providers track your weekly weight, appetite suppression, energy levels, and any side effects through ongoing assessments. If you're experiencing moderate nausea that persists beyond day 3 or 4 of a new dose, you may hold at your current level for an extra week rather than advancing. The goal is reaching your therapeutic dose (usually 1.0 to 2.4 mg weekly) while staying comfortable and compliant with the full titration schedule.

Why Standard Dosing May Not Work for Everyone

Your genetics significantly influence how well semaglutide works and what dose delivers optimal results. Variants in the GLP1R gene (rs6923761), GIPR receptor pathway (rs1800437), and appetite regulation genes like FTO (rs9939609) directly affect how your body responds to the medication. Two patients following the same titration schedule may experience dramatically different effectiveness at the same dose.

PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 150+ genetic insights to reveal your individual peptide sensitivity. Patients with specific GLP1R variants may see excellent results at 1.0 mg weekly, while others with different genetic profiles might require the full 2.4 mg dose for comparable appetite suppression. Testing before your first month ends helps your provider skip ineffective doses and accelerate you toward your personal therapeutic dose faster.

Managing Side Effects During Dose Increases

Nausea is the most common side effect during titration, typically peak on days 1 to 3 after a dose increase and improving by day 4 or 5. Staying hydrated, eating small frequent meals, and avoiding high-fat foods helps your body adjust. If nausea persists beyond one week at a dose, holding steady for 7 to 14 additional days before advancing allows your tolerance to build without compromising your treatment timeline.

Fatigue, constipation, or decreased appetite for favorite foods are expected responses to semaglutide and usually indicate the medication is working as intended. However, severe vomiting, dizziness, or signs of dehydration require immediate communication with your PlexusDx provider—these warrant dose pausing or reduction rather than advancement. Your provider has protocols to safely manage side effects while keeping you progressing toward your goal dose and sustainable weight loss results.

Reaching Your Maintenance Dose and Beyond

Most patients reach their maintenance dose of 1.0 to 2.4 mg weekly after 16 to 20 weeks of consistent titration. At this stage, weight loss typically plateaus initially before you stabilize at your new lower weight set-point. Some patients maintain excellent results indefinitely at 1.0 mg, while others benefit from the full 2.4 mg dose for continued appetite control and metabolic support.

If you plateau on weight loss after six to eight weeks at maintenance dose, PlexusDx providers may recommend continuing at your current dose (consistency amplifies results over time) or exploring alternative treatments like Tirzepatide, which targets additional hormone pathways. Your dose may need to go up—your price won't. PlexusDx pricing remains flat monthly regardless of your dose tier, ensuring cost-effective access to your optimal treatment throughout your entire weight loss journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How often should I increase my semaglutide dose?

Most patients increase their dose weekly, moving from 0.25 mg to 0.5 mg to 0.75 mg to 1.0 mg and potentially higher over 4 to 5 weeks. If side effects are significant or you're titrating slowly, your PlexusDx provider may recommend holding at a dose for one or two extra weeks before advancing. The standard protocol allows personalization based on your tolerance and response.

What does clinical data say about optimal semaglutide dosing?

Clinical trials showed that patients using 2.4 mg weekly achieved approximately 15% to 22% weight loss over 68 weeks compared to placebo. However, many patients experience substantial results at 1.0 to 1.5 mg weekly. Your individual genetic profile and metabolic response determine your personal optimal dose, which is why genetic testing through PlexusDx helps identify the right target faster.

How much does semaglutide cost at PlexusDx if I need to increase my dose?

PlexusDx Compounded Semaglutide Injection starts at $149 per month and remains flat across all dose levels—your dose may need to go up, your price won't. No insurance is required, and HSA/FSA accounts are eligible. Pricing is transparent and consistent whether you're at 0.25 mg or 2.4 mg weekly.

Is nausea during dose increases normal, and when should I worry?

Mild nausea during the first 3 to 5 days after a dose increase is expected and typically resolves as your body adapts. However, severe vomiting, inability to keep fluids down, or signs of dehydration warrant immediate contact with your PlexusDx provider. Your provider may pause or reduce your dose temporarily to manage these symptoms safely while keeping you on track.

Can the PlexusDx Precision Peptide Genetic Test help determine my ideal dose?

Yes. PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that directly influence semaglutide response and sensitivity. Testing after your first month of treatment ($99 add-on) reveals your genetic peptide profile across 14 pathways, helping your provider target your personal therapeutic dose more precisely and avoid ineffective titration steps.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves